Feed/Investors/Harel Insurance

Harel Insurance

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2022-01-06

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$517.8M

across 1 round

LATEST ROUND

Series B · $517.8M · 2022-01-06

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Eikon Therapeutics Eikon is a late-stage clinical biopharmaceutical company focused on inventing and developing breakthrough therapeutics for serious illnesses through innovative scientific and engineering approaches.	Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$517.8M	2022-01-06	[ PART ]